ATR

Aptargroup

• TipRanks·06/11 02:09

  Top AptarGroup Executive Makes Bold Insider Move

• TipRanks·06/06 02:04

  Top AptarGroup Executive Makes Notable Insider Move With Major Stock Sale

• TipRanks·05/28 02:17

  Top AptarGroup Executive Quietly Unloads a Significant Chunk of Shares

• Seeking Alpha·05/23 01:11

  Dividend Champion, Contender, And Challenger Highlights: Week Of May 24

• TipRanks·05/20 00:44

  AptarGroup Balances Profit Pressures With Pharma Momentum

• TipRanks·05/13 11:35

  AptarGroup Appoints New Vice President and Chief Accounting Officer

• NASDAQ·05/09 22:06

  AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot

• TipRanks·05/09 02:07

  Top AptarGroup Executive Makes Notable Insider Move That Investors Can’t Ignore

• Dow Jones·05/04 19:03

  AptarGroup Is Maintained at Overweight by Wells Fargo

• TipRanks·05/02 00:10

  AptarGroup Earnings Call Balances Growth With Margin Strain

• Seeking Alpha·05/01 22:04

  Dividend Champion, Contender, And Challenger Highlights: Week Of May 3

• Seeking Alpha·05/01 20:32

  Aptar forecasts Q2 adjusted EPS of $1.32-$1.40 as emergency medicine destocking tracks ~$65M 2026 headwind

• TipRanks·04/30 22:30

  Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR) and Viridian Therapeutics (VRDN)

• NASDAQ·04/30 21:42

  AptarGroup Inc. Reports Retreat In Q1 Income

• TipRanks·04/30 21:09

  AptarGroup sees Q2 EPS $1.32-$1.40, consensus $1.34